Jul 20, 2026 06:51AM
Jun 30, 2026 06:44AM
May 7, 2026 06:39PM
Mar 27, 2026 04:13PM
Mar 20, 2026 06:48AM
Mar 19, 2026 07:38AM
Mar 19, 2026 05:42AM 4D Molecular Therapeutics (FDMT) PT Raised to $35 at RBC Capital
Jan 7, 2026 10:22AM
Nov 11, 2025 08:39AM
Nov 10, 2025 05:01PM
Nov 7, 2025 04:28AM
Oct 31, 2025 09:20AM
Oct 21, 2025 09:11AM
Aug 11, 2025 11:34AM Goldman Sachs Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Aug 11, 2025 11:33AM
Aug 11, 2025 10:54AM
Jul 2, 2025 04:07PM
May 8, 2025 07:30PM
May 1, 2025 08:01AM
Feb 10, 2025 02:30PM
Feb 10, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Jan 13, 2025 06:20AM
Jan 13, 2025 04:43AM
Jan 10, 2025 08:07AM
Nov 21, 2024 04:25AM
Sep 20, 2024 06:46AM
Sep 19, 2024 08:14AM
Sep 19, 2024 08:06AM Chardan Capital Markets Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Sep 19, 2024 06:46AM
Sep 19, 2024 05:25AM
Aug 12, 2024 12:41PM
Aug 9, 2024 06:43AM
Jul 22, 2024 06:24AM
Jul 18, 2024 08:56AM
Jul 17, 2024 01:19PM 4D Molecular Therapeutics tumbles following mid-stage clinical study results
Jul 17, 2024 01:07PM
Jul 9, 2024 07:00PM
Jun 26, 2024 05:40AM
Jun 10, 2024 08:58AM

423,290 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All